Similar articles

• Branched-chain amino and keto acids and aromatic amino acids profile in uremia: nutritional or metabolic defect?

  Cappelli P, Evangelista M, Del Rosso G, Di Paolo B, Palmieri PF, Albertazzi A, Langer K. Cappelli P, et al. Contrib Nephrol. 1990;81:181-7. doi: 10.1159/000418751. Contrib Nephrol. 1990. PMID: 2093495 No abstract available.
• Comparative studies between rates of incorporation of branched-chain amino acids and their alpha-ketoanalogues into rat tissue proteins under different dietary conditions.

  Hauschildt S, Brand K. Hauschildt S, et al. J Nutr Sci Vitaminol (Tokyo). 1984 Apr;30(2):143-52. doi: 10.3177/jnsv.30.143. J Nutr Sci Vitaminol (Tokyo). 1984. PMID: 6470832
• Metabolic acidosis and uremic toxicity: protein and amino acid metabolism.

  Price SR, Mitch WE. Price SR, et al. Semin Nephrol. 1994 May;14(3):232-7. Semin Nephrol. 1994. PMID: 8036357 Review. No abstract available.
• [Branched-chain amino acids and their ketoanalogs: therapeutic uses in patients with chronic liver or kidney failure].

  Bode JC. Bode JC. Internist (Berl). 1985 Jul;26(7):388-98. Internist (Berl). 1985. PMID: 3897107 German. No abstract available.
• Interactions in the Metabolism of Glutamate and the Branched-Chain Amino Acids and Ketoacids in the CNS.

  Yudkoff M. Yudkoff M. Neurochem Res. 2017 Jan;42(1):10-18. doi: 10.1007/s11064-016-2057-z. Epub 2016 Oct 1. Neurochem Res. 2017. PMID: 27696119 Free PMC article. Review.